Glutamate excitotoxicity in a model of multiple sclerosis (original) (raw)

Nature Medicine volume 6, pages 67–70 (2000)Cite this article

Abstract

Glutamate excitotoxicity mediated by the AMPA/kainate type of glutamate receptors damages not only neurons but also the myelin-producing cell of the central nervous system, the oligodendrocyte1. In multiple sclerosis, myelin, oligodendrocytes and some axons are lost as a result of an inflammatory attack on the central nervous system2. Because glutamate is released in large quantities by activated immune cells3, we expected that during inflammation in MS, glutamate excitotoxicity might contribute to the lesion. We addressed this by using the AMPA/kainate antagonist NBQX to treat mice sensitized for experimental autoimmune encephalomyelitis, a demyelinating model that mimics many of the clinical and pathologic features of multiple sclerosis. Treatment resulted in substantial amelioration of disease, increased oligodendrocyte survival and reduced dephosphorylation of neurofilament H, an indicator of axonal damage4. Despite the clinical differences, treatment with NBQX had no effect on lesion size and did not reduce the degree of central nervous system inflammation. In addition, NBQX did not alter the proliferative activity of antigen-primed T cells in vitro, further indicating a lack of effect on the immune system. Thus, glutamate excitotoxicity seems to be an important mechanism in autoimmune demyelination, and its prevention with AMPA/kainate antagonists may prove to be an effective therapy for multiple sclerosis.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. McDonald, J.W., Althomsons, S.P., Hyrc, K.L., Choi, D. & Goldberg, M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4, 291–297 ( 1998).
    Article CAS Google Scholar
  2. Prineas, J.W. & McDonald, I. in Greenfield's Neuropathology (eds. Graham D.I. & Lantos P.L.) 813–881 (Arnold, New York, 1997).
    Google Scholar
  3. Piani, D., Frei, K., Do, K.Q., Cuénod, M. & Fontana, A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159–162 ( 1991).
    Article CAS Google Scholar
  4. Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278–285 (1998).
    Article CAS Google Scholar
  5. Yoshioka, A., Bacskai, B. & Pleasure, D. Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 46, 427–37 (1996).
    Article CAS Google Scholar
  6. Cannella, B. et al. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 95, 10100–10105 (1998).
    Article CAS Google Scholar
  7. Raine, C.S. in Multiple Sclerosis Clinical and Pathogenetic Basis (eds. Raine, C.S., McFarland, H.F. & Tourtellotte, W.W.) 243–286 (Chapman & Hall, London, 1997).
  8. Szaro, B.G., Whitnall, M.H. & Gainer, H. Phosphorylation-dependent epitopes on neurofilament proteins and neurofilament densities differ in axons in the corticospinal and primary sensory dorsal column tracts in the rat spinal cord. J. Comp. Neurol. 302, 220–235 (1990).
    Article CAS Google Scholar
  9. Rodriguez-Moreno, A., Herreras, O. & Lerma, J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19, 893–901 (1997).
    Article CAS Google Scholar
  10. Selmaj, K.W. & Raine, C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339–346 (1988).
    Article CAS Google Scholar
  11. Gijbels, K., Galardy, R.E. & Steinman, L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177–2182 ( 1994).
    Article CAS Google Scholar
  12. Ding, M. et al. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160, 2560–2564 (1998).
    CAS PubMed Google Scholar
  13. Genain, C.P., Cannella, B., Hauser, S.L. & Raine, C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med. 5, 170– 175 (1999).
    Article CAS Google Scholar
  14. Hardin-Pouzet, H. et al. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20, 79–85 (1997).
    Article CAS Google Scholar
  15. Buryakova, A.V. & Sytinsky, I.A. Amino acid composition of cerebrospinal fluid in acute neuroinfections in children. Arch. Neurol. 32, 28–31 (1975).
    Article CAS Google Scholar
  16. Stover, J.F. et al. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur. J. Clin. Invest. 27, 1038 –43 (1997).
    Article CAS Google Scholar
  17. Rothman, S.M. & Olney, J.W. Excitotoxicity and the NMDA receptor . Trends Neurosci. 10, 299– 302 (1987).
    Article CAS Google Scholar
  18. Collins, R.C., Dobkin, B.H. & Choi, D.W. Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann. Intern. Med. 110, 992–1000 (1989).
    Article CAS Google Scholar
  19. O'Neill, M.J. et al. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology 37, 1211–1222 ( 1998).
    Article CAS Google Scholar
  20. Rosenberg, L.J., Teng, Y.D., Wrathall, J. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci. 19, 464–475 (1999).
    Article CAS Google Scholar
  21. Espey, M.G., Kustova, Y., Sei, Y. & Basile, A.S. Extracellular glutamate levels are chronically elevated in the brains of LP-BM5-infected mice: a mechanism of retrovirus-induced encephalopathy. J. Neurochem. 71, 2079–2087 ( 1998).
    Article CAS Google Scholar
  22. Adams R.D. & Kubik C.S., The morbid anatomy of the demyelinative diseases. Am. J. Med. 12, 510– 518 (1952).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank C. Weaver, F.C. Chiu and B. Cannella for discussions; P. Cobban-Bond for administrative assistance; and M. Pakingan, N. Rempel and E. Swanson for technical assistance. This work was supported in part by the National Multiple Sclerosis Society PP0693 (P.W. and D.P.), the Singer Foundation (P.W.), United States Public Health Service grants NS 08952, NS 11920 and NS 07098; the Sol Goldman Charitable Trust -NMSS RG 1001-I-9; and the Wollowick Family Foundation (C.S.R.). D.P. is a Deutsche Forschungsgemeinschaft postdoctoral fellow.

Author information

Author notes

  1. David Pitt and Peter Werner: D.P and P.W. contributed equally to this study.

Authors and Affiliations

  1. Department of Neurology, F-121N, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, 10461, New York, USA
    Peter Werner & Cedric S. Raine
  2. Department of Pathology, F-121N, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, 10461, New York, USA
    David Pitt & Cedric S. Raine
  3. Dept. of Neurology, Beth Israel Medical Center, 10 Union Square East, New York, 10003, New York, USA
    Peter Werner
  4. Department of Neuroscience, F-121N, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, 10461, New York, USA
    Cedric S. Raine

Authors

  1. David Pitt
    You can also search for this author inPubMed Google Scholar
  2. Peter Werner
    You can also search for this author inPubMed Google Scholar
  3. Cedric S. Raine
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPeter Werner.

Rights and permissions

About this article

Cite this article

Pitt, D., Werner, P. & Raine, C. Glutamate excitotoxicity in a model of multiple sclerosis.Nat Med 6, 67–70 (2000). https://doi.org/10.1038/71555

Download citation

This article is cited by

Associated content